Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

tly in Phase 3 development as a potential treatment for type 2 diabetes.

For more information about HGS, please visit the Company's web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, while the Compa
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Healthcare providers are ... content management (ECM) solution, for a ... System .  These organizations identified enterprise content ... will use OnBase to optimize their Meditech ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., a ... the launch of their web site ( http://www.stephreports.com ... About STEPh Reports STEPh ... Each STEPh Report assesses the competitive ... projected launch year, company, and specific key issues.  STEPh ...
(Date:5/22/2013)... 22, 2013   Life Line Screening  (LLS), ... today the creation of a unique partnership with ... MCM is a population health management organization. LLS ... of clients. These important expanded services will help MCM ... Effective prevention reduces cost of care when individuals are ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
(Date:5/22/2013)... -- Fish oil supplements could help reduce the ... The supplements, also known as omega-3 ... adiponectin that,s linked to insulin sensitivity, Harvard researchers ... bloodstream have also been linked to a lower ... studies found fish oil increased circulating adiponectin, whether ...
(Date:5/22/2013)... A 2012 survey of internal medicine residents at Massachusetts ... teaching hospitals found that more than half rated ... substance use disorders as fair or poor. Significant numbers ... similar to surveys of practicing physicians. In response to ... Substance Abuse , the MGH has increased residents, training ...
(Date:5/22/2013)... depression have on his young son or daughter? When fathers ... their children benefit, said a University of Illinois study. , ... to be able to attend to the child,s emotional state, ... notice whether he is getting frustrated or needs help. Depressed ... U of I professor of human development. , But if ...
(Date:5/22/2013)... IL A new study suggests that disturbed ... of depression and greater uncertainly about future success. ... and teachers appears to have a protective effect. ... significantly associated with depressed mood and greater uncertainty ... from parents and from teachers were associated with ...
(Date:5/22/2013)... to the "power plants" that make energy to keep ... preventing emergence of the drug-resistant forms of cancer ... That,s the conclusion of a new study published in ... Shana Kelley and colleagues explain that doxorubicin and other ... inside the nucleus of cancer cells. Cancer cells divide ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2
... of Psychiatry at Case Western Reserve University School of Medicine ... Institute of Mental Health (NIMH) for the long-term study of ... NIMH, one of the National Institutes of Health (NIH), funds ... which 707 children between the ages of six and 12 ...
... By Maryann Mott HealthDay Reporter , THURSDAY, ... twice before snuggling in bed at night with Fido or ... issue of the public health journal Emerging Infectious Diseases ... that cause mild to life-threatening illness in people. Of ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay ... greatly increases the chances of dying, new research ... analysis, of previously published studies that looked at ... Six of seven studies found pre-existing diabetes was ...
... (HealthDay News) -- Many young American couples can,t agree on ... a new study shows. Oregon State University researchers analyzed ... 18 to 25. In 40 percent of those couples, one ... the other partner said there was no such deal. ...
... paper published Jan. 21 in the journal Science , ... Blossom Damania, PhD, has shown for the first time that ... a key molecule involved in the human immune response. ... Kenan, Jr. Distinguished Professor, Jenny Ting, PhD. First ...
... Ky. Healthcare workers can most directly affect quality of ... helping manage symptoms such as pain, lack of energy, shortness ... a study recently published in the journal Oncology Nursing ... or the degree to which a symptom bothers a person, ...
Cached Medicine News:Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 3Health News:Pets May Pass Illnesses to Owners 2Health News:Pets May Pass Illnesses to Owners 3Health News:Breast Cancer Patients With Diabetes May Fare Worse 2Health News:Breast Cancer Patients With Diabetes May Fare Worse 3Health News:Young Couples Often Disagree About Monogamy, Study Finds 2Health News:Viral protein mimic keeps immune system quiet 2Health News:Controlling symptoms can lead to improved quality of life for end-of-life patients 2
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: